Values First Advisors, Inc. - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Values First Advisors, Inc. ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$243,000
-10.7%
456,022
+13.1%
0.22%
-17.1%
Q2 2020$272,000
+15.2%
403,373
-1.8%
0.27%
-4.9%
Q1 2020$236,125
-16.9%
410,653
+90.7%
0.28%
+3.3%
Q4 2019$284,000–215,313–0.27%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders